|
1
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Saragoni L, Morgagni P, Gardini A, Marfisi
C, Vittimberga G, Garcea D and Scarpi E: Early gastric cancer:
Diagnosis, staging, and clinical impact. Evaluation of 530
patients. New elements for an updated definition and
classification. Gastric Cancer. 16:549–554. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carcas LP: Gastric cancer review. J
Carcinog. 13:142014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gertler AA and Cohen HY: SIRT6, a protein
with many faces. Biogerontology. 14:629–639. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pan PW, Feldman JL, Devries MK, Dong A,
Edwards AM and Denu JM: Structure and biochemical functions of
SIRT6. J Biol Chem. 286:14575–14587. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Houtkooper RH, Pirinen E and Auwerx J:
Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol
Cell Biol. 13:225–238. 2012.PubMed/NCBI
|
|
7
|
Xiao C, Kim H-S, Lahusen T, Wang RH, Xu X,
Gavrilova O, Jou W, Gius D and Deng CX: SIRT6 deficiency results in
severe hypoglycemia by enhancing both basal and insulin-stimulated
glucose uptake in mice. J Biol Chem. 285:36776–36784. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kanfi Y, Peshti V, Gil R, Naiman S, Nahum
L, Levin E, Kronfeld-Schor N and Cohen HY: SIRT6 protects against
pathological damage caused by diet-induced obesity. Aging Cell.
9:162–173. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sundaresan NR, Vasudevan P, Zhong L, Kim
G, Samant S, Parekh V, Pillai VB, Ravindra PV, Gupta M, Jeevanandam
V, et al: The sirtuin SIRT6 blocks IGF-Akt signaling and
development of cardiac hypertrophy by targeting c-Jun. Nat Med.
18:1643–1650. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiao C, Wang R-H, Lahusen TJ, Park O,
Bertola A, Maruyama T, Reynolds D, Chen Q, Xu X, Young HA, et al:
Progression of chronic liver inflammation and fibrosis driven by
activation of c-JUN signaling in Sirt6 mutant mice. J Biol Chem.
287:41903–41913. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mao Z, Tian X, Van Meter M, Ke Z,
Gorbunova V and Seluanov A: Sirtuin 6 (SIRT6) rescues the decline
of homologous recombination repair during replicative senescence.
Proc Natl Acad Sci USA. 109:11800–11805. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sebastián C, Zwaans BM, Silberman DM,
Gymrek M, Goren A, Zhong L, Ram O, Truelove J, Guimaraes AR, Toiber
D, et al: The histone deacetylase SIRT6 is a tumor suppressor that
controls cancer metabolism. Cell. 151:1185–1199. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Z-G and Qin C-Y: Sirt6 suppresses
hepatocellular carcinoma cell growth via inhibiting the
extracellular signal-regulated kinase signaling pathway. Mol Med
Rep. 9:882–888. 2014.PubMed/NCBI
|
|
14
|
Lu C-T, Hsu C-M, Lin P-M, Lai CC, Lin HC,
Yang CH, Hsiao HH, Liu YC, Lin HY, Lin SF, et al: The potential of
SIRT6 and SIRT7 as circulating markers for head and neck squamous
cell carcinoma. Anticancer Res. 34:7137–7143. 2014.PubMed/NCBI
|
|
15
|
Khongkow M, Olmos Y, Gong C, Gomes AR,
Monteiro LJ, Yagüe E, Cavaco TB, Khongkow P, Man EP, Laohasinnarong
S, et al: SIRT6 modulates paclitaxel and epirubicin resistance and
survival in breast cancer. Carcinogenesis. 34:1476–1486. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Y, Xie QR, Wang B, Shao J, Zhang T,
Liu T, Huang G and Xia W: Inhibition of SIRT6 in prostate cancer
reduces cell viability and increases sensitivity to
chemotherapeutics. Protein Cell. 4:702–710. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mao Z, Hine C, Tian X, Van Meter M, Au M,
Vaidya A, Seluanov A and Gorbunova V: SIRT6 promotes DNA repair
under stress by activating PARP1. Science. 332:1443–1446. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chiang W-C, Tishkoff DX, Yang B,
Wilson-Grady J, Yu X, Mazer T, Eckersdorff M, Gygi SP, Lombard DB
and Hsu AL: C. elegans SIRT6/7 homolog SIR-2.4 promotes
DAF-16 relocalization and function during stress. PLoS Genet.
8:e10029482012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roth M and Chen WY: Sorting out functions
of sirtuins in cancer. Oncogene. 33:1609–1620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Van Meter M, Mao Z, Gorbunova V and
Seluanov A: SIRT6 overexpression induces massive apoptosis in
cancer cells but not in normal cells. Cell Cycle. 10:3153–3158.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barneda-Zahonero B and Parra M: Histone
deacetylases and cancer. Mol Oncol. 6:579–589. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Leiser SF, Fletcher M, Begun A and
Kaeberlein M: Life-span extension from hypoxia in Caenorhabditis
elegans requires both HIF-1 and DAF-16 and is antagonized by
SKN-1. J Gerontol A Biol Sci Med Sci. 68:1135–1144. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Judd LM, Menheniott TR, Ling H, Jackson
CB, Howlett M, Kalantzis A, Priebe W and Giraud AS: Inhibition of
the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and
in vivo. PLoS One. 9:e959932014. View Article : Google Scholar : PubMed/NCBI
|
